Joint Pain Injections Market to Grow with a CAGR of 7.76% through 2031
Changes in patient preferences, technological advancements, and increasing awareness are expected to drive growth in the Global Joint Pain Injections Market over the forecast period, 2027-2031.
According to TechSci Research's report, “Joint Pain Injections Market – Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2031F,” the global joint pain injections market is projected to grow from USD 4.72 billion in 2025 to USD 7.39 billion by 2031, at a 7.76% CAGR. This can be attributed to emerging markets. While
North America and Europe have traditionally dominated the joint pain injections
market, emerging economies in the Asia-Pacific region are now contributing to
its growth. The growing middle-class population in countries such as India and China, along with improved healthcare infrastructure, is expanding the
market's reach.
Furthermore, increasing patient education and
empowerment is a pivotal trend in the market for joint pain injections. Patients
are becoming more involved in their healthcare decisions, thanks to the
availability of information and support. Educated patients are more likely to
consider and elect joint pain injections because they understand the benefits and risks of these treatments.
The global market under study was significantly affected by the COVID-19 pandemic, primarily due to pandemic-related restrictions that constrained the diagnosis and treatment of chronic diseases worldwide. For instance, a research article titled "COVID-19 and Rheumatoid Arthritis," published in May 2021, highlighted the vulnerability of older patients with rheumatoid arthritis (RA) to COVID-19. The RA patient community experienced disruptions in accessing care, a transition to telemedicine, shortages of essential medications, increased anxiety, and social isolation, all contributing to disease flares. Access to therapy was constrained during the pandemic, with 42% of patients reporting canceled or postponed appointments and a shift to telemedicine visits. Consequently, COVID-19 had an adverse impact on the market for joint pain injections.
Browse over XX market data Figures spread
through XX Pages and an in-depth TOC on "Global Joint
Pain Injections Market”
The Global Joint Pain Injections Market is segmented by injection type, application, region, and company.
Based on its type of injection, The Hyaluronic Acid Injections segment is expected to be the fastest-growing in the coming years, fueled by increasing demand for non-surgical treatments for knee osteoarthritis. As patients and clinicians seek alternatives to repeated corticosteroid use, hyaluronic acid injections are gaining traction for their safety and effectiveness in managing joint pain. Continued innovation by market players, including the launch of advanced formulations such as cross-linked hyaluronate hydrogels, is enhancing treatment outcomes and increasing adoption. These developments, along with growing awareness and an aging global population, are accelerating the segment’s expansion within the osteoarthritis treatment landscape.
Major companies operating in Global Joint Pain
Injections Market are:
- Anika Therapeutics Inc
- Bioventus LLC
- Ferring Pharmaceuticals Inc
- Sanofi SA
- Pfizer Inc
- Eli Lilly & Co
- Flexion Therapeutics Inc
- Teva Pharmaceutical Industries Ltd
- Zimmer Biomet Holdings, Inc.
Download
Free Sample Report
Customers can also request for 10%
free customization on this report.
“The global joint pain injections market is on the
cusp of transformative change. As personalized medicine, advanced biologics,
telemedicine, AI-driven treatments, and other trends gain momentum, the market
is expected to provide more effective, patient-centric solutions for joint pain
management. These innovations promise to improve the lives of millions of
individuals suffering from joint pain, further fueling the growth of this
dynamic and evolving healthcare sector,” said Mr. Karan Chechi, Research Director
with TechSci Research, a research-based management consulting firm.
“Joint Pain Injections Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type of Injection (Steroid Joint Injections, Hyaluronic Acid Injections, Platelet-rich Plasma (PRP) Injections, Placental Tissue Matrix (PTM) Injections, Others), By Application (Shoulder & Elbow, Knee & Ankle, Spinal Joints, Hip Joint, Others), By Region & Competition, 2021-2031F”, has evaluated the future growth potential of Global
Joint Pain Injections Market and provides statistics & information on
market size, structure and future market growth. The report aims to provide cutting-edge market intelligence and help decision-makers make sound investment
decisions. Besides, the report also identifies and analyzes the emerging trends
along with essential drivers, challenges, and opportunities in Global Joint
Pain Injections Market.
Contact
Techsci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com